Dermatitis News

Children and adults with atopic dermatitis are at an increased risk for inflammatory bowel disease, ulcerative colitis and Chron’s disease, according to a study.

In this edition, nearly $1 million in grants to aid diversity, equity, inclusion research; topical halcinonide may benefit patients with psoriasis; Asian patients may experience earlier mycosis fungoides diagnosis and more.

Children and adolescents with atopic dermatitis treated with long-term dupilumab showed positive results and acceptable safety, according to a meta-analysis of multiple studies.

The POCN has launched its Atopic Dermatitis Center of Excellence, a free online resource center for nurse practitioners and physician associates working in the atopic dermatitis field, according to a press release.

Greater atopic dermatitis severity correlated with greater disease burden in children and adolescents in Japan, according to a study.

Dupilumab significantly improved sleep quality, reducing the number of times patients with atopic dermatitis woke up in the middle of the night with pain and itchiness, according to a study.

Changes in the gut microbiota of infants preceded the development of eczema, according to a study published in mSystems.

Treatment with dupilumab reduced Staphylococcus aureus colonization and infection in patients with atopic dermatitis, correlating with improved outcomes, according to a study published in The Journal of Allergy and Clinical Immunology.

Moderate to severe pruritus remains a chronic problem in patients on maintenance hemodialysis that can reduce overall quality of life, according to recently published data.

PARK CITY, Utah — Physicians should mind variations in atopic dermatitis presentation among patients of different races, according to a presentation here.